New study finds early detection of miRNAs in maternal blood may offer potential for predicting preeclampsia

Preeclampsia (PE) is a significant contributor to the increase in maternal morbidity and mortality worldwide, with particularly alarming numbers in the United States, where it affects about 2–8% of pregnancies, resulting in premature birth with associated morbidities for their infants as well. A new study by researchers at UCLA Health finds that early detection of specific microRNAs (miRNAs) packaged in vesicles may offer the opportunity to predict preeclampsia in pregnant people before clinical symptoms manifest. The work appears in Scientific Reports. The study, led by Dr. Sherin U. Devaskar, MD, executive chair of the Department of Pediatrics and physician-in-chief at Read More